Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Bare Lymphocyte Syndrome
Symptoms, Doctors, Treatments, Advances & More
Overview
Find a Doctor
Latest Advances
Clinical Trials
Condition 101
About Bare Lymphocyte Syndrome
What are the alternative names for Bare Lymphocyte Syndrome?
BLS type 1
HLA class 1 deficiency
Top Global Doctors
For Bare Lymphocyte Syndrome
Bookmark
Click to see options
JP
Elite
Jennifer M. Puck
Pediatrics
Immunology
San Francisco, CA
Bookmark
Click to see options
LN
Elite
Luigi D. Notarangelo
Pediatrics
Immunology
Internal Medicine
Boston, MA
Bookmark
Click to see options
AF
Elite
Alain H. Fischer
Paris, FR
Bookmark
Click to see options
HG
Elite
Hubert B. Gaspar
London, ENG, GB
Bookmark
Click to see options
CD
Elite
Christopher C. Dvorak
Pediatrics
Hematology
Oncology
San Francisco, CA
Bookmark
Click to see options
RB
Elite
Rebecca H. Buckley
Pediatrics
Immunology
Allergy and Immunology
Durham, NC
Latest Advances
On Bare Lymphocyte Syndrome
Condition:
Novel Mutation in RFXANK Gene and Low B Cell Count in Patient with MHC Class II Deficiency
Journal:
Immunologic research
Treatment Used:
Intravenous Immunoglobulin Infusion, Hematopoietic Stem Cell Transplantation
Number of Patients:
1
Published —
June 25, 2020
This case report describes a 5-year-old boy diagnosed with a novel mutation in RFXANK gene and low B cell count in a patient with MHC class II deficiency treated with intravenous immunoglobulin infusion.
Condition:
Adenosine deaminase-deficient
Journal:
Clinical immunology (Orlando, Fla.)
Treatment Used:
Enzyme replacement therapy
Number of Patients:
1
Published —
December 09, 2019
The study researched an adenosine deaminase-deficient patient who used enzyme replacement therapy for 27 years.
Clinical Trials
For Bare Lymphocyte Syndrome
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Biological
Participants:
8
Start Date:
August 2021
Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency
Clinical Trial
Status:
Recruiting
Intervention Type:
Drug
Participants:
50
Start Date:
August 20, 2020
A Prospective Outcomes Study of Pediatric and Adult Patients With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation With a Reduced-Intensity Conditioning Regimen (PRO-RIC)